Matrifen (Fentanyl)

Matrifen (fentanyl) is used in the management of pain conditions that require strong opioid therapy.

• Severe chronic non‑cancer pain: provides continuous analgesia for patients with long‑term pain unresponsive to weaker opioids.
• Cancer‑related pain: delivers steady opioid levels to control moderate to severe pain in oncology patients.
• End‑of‑life pain management: ensures consistent pain relief for patients in palliative care settings.

• Fentanyl binds with high affinity to mu‑opioid receptors in the central nervous system, activating inhibitory G‑protein pathways that reduce neuronal excitability and diminish the perception of pain. When delivered through a transdermal patch, the drug is absorbed slowly into systemic circulation, maintaining stable plasma concentrations over several days.

Fentanyl transdermal therapy may be associated with a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects

• Nausea: feeling of sickness or urge to vomit.
• Constipation: reduced bowel movements and hard stools.
• Dizziness: light‑headedness or unsteady sensation.
• Somnolence: increased sleepiness or fatigue.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing that can be life‑threatening.
• Severe hypotension: marked drop in blood pressure causing dizziness or fainting.
• Opioid dependence or withdrawal: risk of addiction and withdrawal symptoms upon abrupt discontinuation.

When prescribing Matrifen, clinicians should observe several safety measures to minimize risk.

• Assess opioid tolerance: confirm patient has prior exposure to strong opioids before initiating therapy.
• Evaluate respiratory function: perform baseline assessment and monitor for depression.
• Monitor for signs of addiction: watch for drug‑seeking behavior and dependence.
• Adjust dose in hepatic impairment: reduce dosage or extend interval in patients with liver dysfunction.
• Use with caution in elderly: start at the lowest effective dose and observe closely.
• Store at room temperature: keep patch in original packaging, protect from moisture and light.

Fentanyl may interact with other medicines, altering its effect or increasing adverse reactions.

Major Interactions (Avoid)

• Central nervous system depressants (e.g., benzodiazepines): can cause profound sedation and respiratory depression.
• Monoamine oxidase inhibitors: increase risk of serotonin syndrome and severe hypotension.
• Strong CYP3A4 inhibitors (e.g., ketoconazole): raise fentanyl plasma levels and risk of toxicity.

Moderate Interactions (Monitor Closely)

• CYP3A4 inducers (e.g., rifampin): may reduce fentanyl effectiveness.
• Diuretics: can enhance hypotensive effects when combined with fentanyl.